Literature DB >> 22527233

Importance of CAG repeat length in childhood-onset dentatorubral-pallidoluysian atrophy.

Shinsuke Maruyama1, Yoshiaki Saito, Eiji Nakagawa, Takashi Saito, Hirofumi Komaki, Kenji Sugai, Masayuki Sasaki, Satoko Kumada, Yuko Saito, Hajime Tanaka, Narihiro Minami, Yu-Ichi Goto.   

Abstract

To elucidate a relationship between CAG repeat expansion length and disease progression history in patients with childhood-onset dentatorubral-pallidoluysian atrophy (DRPLA). We retrospectively evaluated information from nine Japanese patients with disease onset reported as between 6 months and 12 years of age. CAG repeat length in these patients ranged from 62 to 93. A strong correlation was confirmed for the age of disease onset, with the onset of epilepsy and involuntary movements, emergence of regression, and autonomic symptoms. The age at becoming wheelchair-bound and initiation of tube feeding also showed a significant correlation with CAG repeat length. This is the first report detailing this aspect of DRPLA focusing on the childhood-onset population. Earlier disease milestones were revealed compared to the expected age based upon a previous report that contained data from the entire patient population, including adult-onset cases (Hasegawa et al. in Mov Disord 25:1694-1700, 2010). These results provide a basis for predicting the outcome of patients in this particular age group, as well as for assessing the results of future clinical therapeutic trials.

Entities:  

Mesh:

Year:  2012        PMID: 22527233     DOI: 10.1007/s00415-012-6493-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  Severe infantile dentatorubral pallidoluysian atrophy with extreme expansion of CAG repeats.

Authors:  Y Shimojo; Y Osawa; M Fukumizu; S Hanaoka; H Tanaka; F Ogata; M Sasaki; K Sugai
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

2.  The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset.

Authors:  J Michael Andresen; Javier Gayán; Luc Djoussé; Simone Roberts; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; James F Gusella; Marcy E MacDonald; Richard H Myers; David E Housman; Nancy S Wexler
Journal:  Ann Hum Genet       Date:  2006-12-19       Impact factor: 1.670

3.  Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy.

Authors:  H Naito; S Oyanagi
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

4.  Long-term disability and prognosis in dentatorubral-pallidoluysian atrophy: a correlation with CAG repeat length.

Authors:  Arika Hasegawa; Takeshi Ikeuchi; Ryoko Koike; Nae Matsubara; Miyuki Tsuchiya; Hiroaki Nozaki; Atsushi Homma; Jiro Idezuka; Masatoyo Nishizawa; Osamu Onodera
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

5.  A general method for the detection of large CAG repeat expansions by fluorescent PCR.

Authors:  J P Warner; L H Barron; D Goudie; K Kelly; D Dow; D R Fitzpatrick; D J Brock
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

Review 6.  The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.

Authors:  Peter O Bauer; Nobuyuki Nukina
Journal:  J Neurochem       Date:  2009-07-23       Impact factor: 5.372

7.  DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation.

Authors:  O Komure; A Sano; N Nishino; N Yamauchi; S Ueno; K Kondoh; N Sano; M Takahashi; N Murayama; I Kondo
Journal:  Neurology       Date:  1995-01       Impact factor: 9.910

8.  Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA).

Authors:  R Koide; T Ikeuchi; O Onodera; H Tanaka; S Igarashi; K Endo; H Takahashi; R Kondo; A Ishikawa; T Hayashi
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

9.  Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p.

Authors:  S Nagafuchi; H Yanagisawa; K Sato; T Shirayama; E Ohsaki; M Bundo; T Takeda; K Tadokoro; I Kondo; N Murayama
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

10.  Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat.

Authors:  T Ikeuchi; R Koide; H Tanaka; O Onodera; S Igarashi; H Takahashi; R Kondo; A Ishikawa; A Tomoda; T Miike
Journal:  Ann Neurol       Date:  1995-06       Impact factor: 10.422

  10 in total
  6 in total

1.  Neonatal SCA2 Presenting With Choreic Movements and Dystonia With Dystonic Jerks, Retinitis, Seizures, and Hypotonia.

Authors:  Marcela Amaral Avelino; José Luiz Pedroso; Antonio Orlacchio; Orlando Graziani Povoas Barsottini; Marcelo Rodrigues Masruha
Journal:  Mov Disord Clin Pract       Date:  2014-06-11

2.  Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs.

Authors:  Shigehiro Nagai; Yoshiaki Saito; Yukari Endo; Takashi Saito; Kenji Sugai; Akihiko Ishiyama; Hirofumi Komaki; Eiji Nakagawa; Masayuki Sasaki; Kimiteru Ito; Yuko Saito; Sayuri Sukigara; Masayuki Ito; Yu-Ichi Goto; Shuichi Ito; Kentaro Matsuoka
Journal:  J Neurol       Date:  2012-12-23       Impact factor: 4.849

Review 3.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

4.  Sleep Related Problems as a Nonmotor Symptom of Dentatorubropallidoluysian Atrophy.

Authors:  Hyeyun Kim; Ji Young Yun; Kyoung-Gyu Choi; Heasoo Koo; Hyun Jeong Han
Journal:  J Korean Med Sci       Date:  2018-04-11       Impact factor: 2.153

Review 5.  Dentatorubral-pallidoluysian Atrophy: An Update.

Authors:  Liam S Carroll; Thomas H Massey; Mark Wardle; Kathryn J Peall
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-10-01

6.  DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.

Authors:  Aiysha Chaudhry; Alkyoni Anthanasiou-Fragkouli; Henry Houlden
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.